These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19484125)

  • 1. Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription.
    Yang L; Calingasan NY; Thomas B; Chaturvedi RK; Kiaei M; Wille EJ; Liby KT; Williams C; Royce D; Risingsong R; Musiek ES; Morrow JD; Sporn M; Beal MF
    PLoS One; 2009 Jun; 4(6):e5757. PubMed ID: 19484125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease.
    Stack C; Ho D; Wille E; Calingasan NY; Williams C; Liby K; Sporn M; Dumont M; Beal MF
    Free Radic Biol Med; 2010 Jul; 49(2):147-58. PubMed ID: 20338236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective role of Nrf2 for retinal ganglion cells in ischemia-reperfusion.
    Xu Z; Cho H; Hartsock MJ; Mitchell KL; Gong J; Wu L; Wei Y; Wang S; Thimmulappa RK; Sporn MB; Biswal S; Welsbie DS; Duh EJ
    J Neurochem; 2015 Apr; 133(2):233-41. PubMed ID: 25683606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis.
    To C; Ringelberg CS; Royce DB; Williams CR; Risingsong R; Sporn MB; Liby KT
    Carcinogenesis; 2015 Jul; 36(7):769-81. PubMed ID: 25939751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling.
    Liby K; Hock T; Yore MM; Suh N; Place AE; Risingsong R; Williams CR; Royce DB; Honda T; Honda Y; Gribble GW; Hill-Kapturczak N; Agarwal A; Sporn MB
    Cancer Res; 2005 Jun; 65(11):4789-98. PubMed ID: 15930299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Nrf2 in Astrocytes Suppressed PD-Like Phenotypes via Antioxidant and Autophagy Pathways in Rat and Drosophila Models.
    Guo Q; Wang B; Wang X; Smith WW; Zhu Y; Liu Z
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis.
    Neymotin A; Calingasan NY; Wille E; Naseri N; Petri S; Damiano M; Liby KT; Risingsong R; Sporn M; Beal MF; Kiaei M
    Free Radic Biol Med; 2011 Jul; 51(1):88-96. PubMed ID: 21457778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDDO-Im protects from acetaminophen hepatotoxicity through induction of Nrf2-dependent genes.
    Reisman SA; Buckley DB; Tanaka Y; Klaassen CD
    Toxicol Appl Pharmacol; 2009 Apr; 236(1):109-14. PubMed ID: 19371629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils.
    Thimmulappa RK; Fuchs RJ; Malhotra D; Scollick C; Traore K; Bream JH; Trush MA; Liby KT; Sporn MB; Kensler TW; Biswal S
    Antioxid Redox Signal; 2007 Nov; 9(11):1963-70. PubMed ID: 17822364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores endothelial function impaired by reduced Nrf2 activity in chronic kidney disease.
    Aminzadeh MA; Reisman SA; Vaziri ND; Shelkovnikov S; Farzaneh SH; Khazaeli M; Meyer CJ
    Redox Biol; 2013; 1(1):527-31. PubMed ID: 24363993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole.
    Yates MS; Kwak MK; Egner PA; Groopman JD; Bodreddigari S; Sutter TR; Baumgartner KJ; Roebuck BD; Liby KT; Yore MM; Honda T; Gribble GW; Sporn MB; Kensler TW
    Cancer Res; 2006 Feb; 66(4):2488-94. PubMed ID: 16489057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide.
    Shin S; Wakabayashi J; Yates MS; Wakabayashi N; Dolan PM; Aja S; Liby KT; Sporn MB; Yamamoto M; Kensler TW
    Eur J Pharmacol; 2009 Oct; 620(1-3):138-44. PubMed ID: 19698707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDDO-Im exerts antidepressant-like effects via the Nrf2/ARE pathway in a rat model of post-stroke depression.
    Hou X; Liu H; Ping Y; Zhang F; Zhi L; Jiang X; Zhang F; Song C; Zhang Z; Song J
    Brain Res Bull; 2021 Aug; 173():74-81. PubMed ID: 33991607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The triterpenoid CDDO-imidazolide ameliorates mouse liver ischemia-reperfusion injury through activating the Nrf2/HO-1 pathway enhanced autophagy.
    Xu D; Chen L; Chen X; Wen Y; Yu C; Yao J; Wu H; Wang X; Xia Q; Kong X
    Cell Death Dis; 2017 Aug; 8(8):e2983. PubMed ID: 28796242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Nrf2 triterpenoid activator, CDDO-imidazolide, protects kidneys from ischemia-reperfusion injury in mice.
    Liu M; Reddy NM; Higbee EM; Potteti HR; Noel S; Racusen L; Kensler TW; Sporn MB; Reddy SP; Rabb H
    Kidney Int; 2014 Jan; 85(1):134-41. PubMed ID: 24088953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Point Mutation at C151 of
    Gatbonton-Schwager T; Yagishita Y; Joshi T; Wakabayashi N; Srinivasan H; Suzuki T; Yamamoto M; Kensler TW
    Mol Pharmacol; 2023 Aug; 104(2):51-61. PubMed ID: 37188495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role of Nrf2 in oxidative stress-induced retinal ganglion cell death.
    Himori N; Yamamoto K; Maruyama K; Ryu M; Taguchi K; Yamamoto M; Nakazawa T
    J Neurochem; 2013 Dec; 127(5):669-80. PubMed ID: 23721546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDDO-Me, Sulforaphane and tBHQ attenuate the RANKL-induced osteoclast differentiation via activating the NRF2-mediated antioxidant response.
    Xue P; Hu X; Powers J; Nay N; Chang E; Kwon J; Wong SW; Han L; Wu TH; Lee DJ; Tseng H; Ko CC
    Biochem Biophys Res Commun; 2019 Apr; 511(3):637-643. PubMed ID: 30826055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of the Nrf2 activators tBHQ and CDDO-Im on the early events of T cell activation.
    Zagorski JW; Turley AE; Freeborn RA; VanDenBerg KR; Dover HE; Kardell BR; Liby KT; Rockwell CE
    Biochem Pharmacol; 2018 Jan; 147():67-76. PubMed ID: 29155145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The triterpenoid CDDO-imidazolide confers potent protection against hyperoxic acute lung injury in mice.
    Reddy NM; Suryanaraya V; Yates MS; Kleeberger SR; Hassoun PM; Yamamoto M; Liby KT; Sporn MB; Kensler TW; Reddy SP
    Am J Respir Crit Care Med; 2009 Nov; 180(9):867-74. PubMed ID: 19679692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.